SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)-LIKE SYNDROMES ASSOCIATED WITH CARBAMAZEPINE THERAPY

被引：31

作者：

JAIN, KK

机构：

[1] Central Drug Monitoring, Medical Department, Ciba-Geigy, Basel

来源：

DRUG SAFETY | 1991年 / 6卷 / 05期

关键词：

D O I：

10.2165/00002018-199106050-00005

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Records of 80 cases of systemic lupus erythematosus (SLE)-like syndromes associated with use of carbamazepine entered in the single case files of Central Drug Monitoring, Ciba-Geigy, Basel, were reviewed. Included in these were 11 cases reported in the literature. These were assessed in light of the current concepts of both idiopathic and drug-induced forms of SLE. Even allowing for under-reporting of adverse drug reactions, the number of such cases is far below the prevalence rates for SLE. This adverse drug reactions remains allocated to the category 'isolated cases' i.e. frequency is < 0.001% of the cases treated. Antinuclear antibody (ANA) and anti-double-stranded DNA (anti-dsDNA) tests were not helpful in differentiating between idiopathic and drug-induced SLE. IgG antihistone antibodies in the absence of high titres of dsDNA antibodies is the only reliable test. Symptoms of SLE-like syndromes which manifest after carbamazepine therapy usually subside after discontinuation of the drug. Persistence of symptoms support the diagnosis of idiopathic SLE.

引用

页码：350 / 360

页数：11

共 53 条

[11]

Cohen M.G., Prowse V., Drug-induced rheumatic syndromes, Medical Toxicology and Adverse Drug Experience, 4, pp. 199-218, (1989)

[12]

Cush J.J., Goldings E.A., Drug-induced lupus: clinical spectrum and pathogenesis, American Journal of Medical Science, 90, pp. 36-45, (1985)

[13]

Drory V.E., Yust I., Korczyn A.D., Carbamazepine-induced systemic lupus erythematosus, Clinical Neuropharmacology, 12, pp. 115-118, (1989)

[14]

Dubois E.L., Wallace D.J., Drugs that exacerbate and induce systemic lupus erythematosus, Dubois’ lupus erythematosus, pp. 450-469, (1987)

[15]

Ellis S.G., Verity A., Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, Seminars in Arthritis and Rheumatism, 8, pp. 212-221, (1979)

[16]

Epstein A., Barland P., The diagnostic value of anti-histone antibodies in drug-induced lupus erythematosis, Arthritis and Rheumatism, 28, pp. 158-162, (1985)

[17]

Feng P.H., Cheah P.S., Lee Y.K., Mortality in systemic lupus erythematosus: a 10-year review, British Medical Journal, 4, pp. 772-774, (1973)

[18]

Fritzler M.J., Tan E.M., Antibodies to histones in drug-induced and idiopathic lupus erythematosus, Journal of Clinical Investigation, 62, pp. 560-567, (1978)

[19]

Fulford K.W.M., Catterall R.D., Delhanty J.J., Et al., A collagen disorder of the nervous system presenting as multiple sclerosis, Brain, 95, pp. 373-386, (1972)

[20]

Gibson T., Myers A., Nervous system involvement in systemic lupus erythematosus, Annals of Rheumatic Diseases, 35, pp. 398-406, (1976)

← 1 2 3 4 5 6 →